Infertility. Female infertility, unspecified
Conditions
Interventions
Intervention 1: women with failure to achieve optimal endometrial thickness in IVF embryo transfer cycle with conventional estrogen therapy are divided to study groups. In group 1, vagifem, 1 tablet B
Treatment - Drugs
women with failure to achieve optimal endometrial thickness in IVF embryo transfer cycle with conventional estrogen therapy are divided to study groups. In group 1, vagifem, 1 tablet Bid (20 microgram
women with failure to achieve optimal endometrial thickness in IVF embryo transfer cycle with conventional estrogen therapy are divided to study groups. In group 2, Premarin cream 1.25 mg/ day (half o
Sponsors
Vice chancellor for research;Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
24 Years to 42 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: women with failure to achieve optimal endometrial thickness in IVF embryo transfer cycle with conventional estrogen therapy. Exclusion criteria: women aged less than 24 or more than 42; previous history of tuberculosis; Asherman syndrome or collagen vascular diseases; smokers and alcohol abusers.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The largest longitudinal endometrial thickness in fundal area. Timepoint: Before intervention and every few days. Method of measurement: Vaginal ultrasonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Measuring level of blood BhCG by ELISA.;Clinical pregnancy. Timepoint: Four weeks after embryo transfer. Method of measurement: Detecting of intrauterine sac by vaginal sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Haghbin
Infertility Research Center
Outcome results
None listed